CoChat

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.

NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies

Open access
García Rodríguez, Luis Alberto, González-Pérez, Antonio, Bueno, Héctor, Hwa, John · 2011 · PLoS ONE

Abstract

BACKGROUND: Recent clinical trials and observational studies have reported increased coronary events associated with non steroidal anti-inflammatory drugs (NSAIDs). There appeared to be a disproportionate increase in non-fatal versus fatal events, however, numbers of fatal events in individual studies were too small, and event rates too low, to be meaningful. OBJECTIVES: We undertook a pooled analysis to investigate the effect of NSAIDs on myocardial infarction (MI) risk with the specific aim to differentiate non-fatal from fatal events. METHODS: We searched Pubmed (January, 1990 to March, 2010) for observational studies and randomised controlled trials that assessed the effect of NSAIDs (traditional or selective COX-2 inhibitors [coxibs]) on MI incidence separately for fatal and non-fatal events. Summary estimates of relative risk (RR) for non-fatal and fatal MIs were calculated with a random effects model. RESULTS: NSAID therapy carried a RR of 1.30 (95% CI, 1.20-1.41) for non-fatal MI with no effect on fatal MI (RR 1.02, 95% CI, 0.89-1.17) in six observational studies. Overall, the risk increase for non-fatal MI was 25% higher (95% CI, 11%-42%) than for fatal MI. The two studies that included only individuals with prior cardiovascular disease presented risk estimates for non-fatal MI on average 58% greater (95% CI, 26%-98%) than those for fatal MI. In nine randomised controlled trials, all investigating coxibs, the pooled RR estimate for non-fatal MI was 1.61 (95% CI, 1.04-2.50) and 0.86 (95% CI 0.51-1.47) for fatal MIs. CONCLUSIONS: NSAID use increases the risk of non-fatal MI with no substantial effect on fatal events. Such differential effects, with potentially distinct underlying pathology may provide insights into NSAID-induced coronary pathology. We studied the association between the use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of myocardial infarction (MI), separating non-fatal from fatal events, summarizing the evidence from both observational studies and randomised controlled trials. An increased risk of non-fatal MI was clearly found in both types of studies while use of NSAID did not confer an increased risk of fatal MI. Our findings provide support for the concept that thrombi generated under NSAID treatment could be different from spontaneous thrombi.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0016780

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study selection process.
Figure 1 Study selection process.CC BY · PubMed Central
Figure 2 Non steroidal anti-inflammatory drugs and risk for non-fatal and fatal myocardial infarctions in observational studies.
Figure 2 Non steroidal anti-inflammatory drugs and risk for non-fatal and fatal myocardial infarctions in observational studies.CC BY · PubMed Central
Figure 3 Non steroidal anti-inflammatory drugs and risk for non-fatal and fatal myocardial infarctions in randomised controlled trials.
Figure 3 Non steroidal anti-inflammatory drugs and risk for non-fatal and fatal myocardial infarctions in randomised controlled trials.CC BY · PubMed Central
Figure 4 Relative risk estimates for non-fatal compared to fatal myocardial infarction risk associated with use of non steroidal anti-inflammatory drugs by type of study.
Figure 4 Relative risk estimates for non-fatal compared to fatal myocardial infarction risk associated with use of non steroidal anti-inflammatory drugs by type of study.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 37 references

Research works printed but not linked: 1

  1. LA García Rodríguez, 2009, Discontinuation of Low-Dose cetylsalicylic Acid Treatment for Secondary Prevention of Cardiovascular Outcomes is Associated With an Increased Risk of Myocardial Infarction., Circulation, 120, S405

Cited by

See all 62

Metadata

Authors
García Rodríguez, L. A., González-Pérez, A., Bueno, H., & Hwa, J.
Affiliations
  • Hospital General Universitario Gregorio Marañón (ES)
  • Yale University (US)
Corresponding author
  • Bueno, Héctor
  • Hwa, John
Venue
PLoS ONE
Published
2011-02-08
Volume
6
Issue
2
Pages
e16780
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2082672105
Cited by
59
References
37
Citations by year
2024: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 10 · 2013: 13 · 2012: 9
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • American Heart Association
  • Pfizer
  • Sanofi
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL074190)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
nonsteroidal anti-inflammatory drugs, nonfatal myocardial infarction, fatal myocardial infarction, COX-2 inhibitors, prior cardiovascular disease
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal, Humans, Myocardial Infarction, Risk, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies. https://app.cochat.ai/papers/10.1371/journal.pone.0016780
The paper
García Rodríguez, L. A., González-Pérez, A., Bueno, H., & Hwa, J. (2011). NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies. PLoS ONE. https://doi.org/10.1371/journal.pone.0016780

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.